SES
10.11.2021 08:52:09 CET | Business Wire | Press release
HSE, leading provider in Europe in the field of live commerce, has extended its partnership with SES in a new multi-year contract that secures additional capacity for the organisation to broadcast its three TV channels including HSE SD, HSE HD and HSE Trend on SES’s satellites in its prime TV neighbourhood at ASTRA 19.2 degrees East.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211109006728/en/
Reaching up to 118 million viewers a year, HSE stands for the most entertaining form of shopping and offers a curated range of fashion, jewelry, beauty, wellness, household and home & living products – all delivered with high-quality picture and sound for an immersive consumer experience. With this multi-year contract, viewers in the region will continue to enjoy free-to-air live commerce via ASTRA 19.2 degrees East in SD and HD, giving HSE access to a wider audience across broadcast standards.
“We are increasingly inspiring more customers with an exclusive product range, which makes shopping at HSE an unforgettable experience every single time. Through the distribution over SES’s ASTRA satellites, our live shows are accessible free-to-air in excellent quality to a wide range of audiences. We are looking forward to continuing our longstanding and successful cooperation,” said Sandra Rehm, Chairwoman of the Management Board of HSE.
“Delivering reliable and high-quality TV content is of upmost importance to both SES and HSE. With our satellites at 19.2 degrees East, HSE is able to supply entertainment and shopping convenience to its viewers across millions of households in Germany. Together, we will continue to help HSE maximise their reach and potential customers,” said Christoph Mühleib, Managing Director of ASTRA Deutschland, part of SES.
Follow us on:
Twitter
Facebook
YouTube
LinkedIn
Instagram
Read our Blogs >
Visit the Media Gallery >
About SES
SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries over 8,500 channels and has an unparalleled reach of 361 million households, delivering managed media services for both linear and non-linear content. The company is listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109006728/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Debiopharm Highlights Clinical Momentum Across DDR Portfolio at ESMO 2026, Advancing WEE1-Based Therapies in Ovarian and Uterine Cancers and Glioblastoma20.10.2026 14:00:00 CEST | Press release
Emerging data highlight encouraging clinical activity of zedoresertib in difficult-to-treat solid tumors, including glioblastoma, provide evidence of brain penetration, and further validate the therapeutic potential of dual WEE1/PKMYT1 inhibition in biomarker-selected populations Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard of care to cure cancer and infectious diseases, today announced their upcoming Phase 1/Phase 2 clinical updates at the European Society for Medical Oncology (ESMO) Congress (Madrid, Spain, 23-27 October). During the event, Debiopharm will highlight clinical updates on its pipeline targeting the DNA Damage Response (DDR), featuring single-agent data on zedoresertib (Debio 0123) as well as rational combination strategies, with both temozolomide in glioblastoma and with lunresertib (Debio2513) in solid tumors. Debiopharm’s planned activities at ESMO 2026 include: Rapid Oral Presentatio
Eight in 10 Professionals Surveyed Say AI Will Boost Restructuring Efficiency, but Execution Gaps Remain20.10.2026 14:00:00 CEST | Press release
82% expect AI to significantly improve restructuring efficiency and decision-making80% value early governance support, but only 24% involve it at that stage43% cite role clarity and cross-border SPV administration as the top execution challenges More than eight in 10 (82%) restructuring professionals expect AI to significantly improve efficiency and decision-making. At the same time, operational readiness and experienced human judgment will remain critical to successful execution. This is according to new research from CSC, the leading provider of global business administration and compliance solutions. CSC surveyed 210 professionals globally across banking and financial services, restructuring and turnaround consulting, legal services, and private credit to examine the operational factors shaping restructuring execution1. The findings are detailed in CSC’s guide The Restructuring Execution Gap—Why operational readiness determinesoutcomes. Respondents see the clearest potential applica
Paris Outpaces London as Europe’s Top AI City, According to The Observer’s AI Cities Index20.10.2026 13:11:00 CEST | Press release
Paris has claimed Europe’s AI crown, ranking higher than London as the continent’s leading hub of AI excellence. Yet Europe is struggling to compete with cities across the US and Asia, whose AI hubs lead the global rankings. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261020799504/en/ The Observer AI Cities Index Top Ten Cities 2026 This is according to The Observer’s inaugural AI Cities Index: a first-of-its-kind report identifying which cities are leading the global AI race when it comes to originating, building, financing and integratingartificial intelligence (AI). The new ranking has scored 57 cities across 36 countries based on levels of AI investment (assessing public, private and procedural investments in AI), innovation (capturing breakthroughs in technology that are indicative of greater capacity for AI in the future) and implementation (the availability of the infrastructure, institutions and systems needed to
New Research from One Biosciences Shows Single-Cell Profiling Can Identify Which Ovarian Cancer Tumors are Predisposed to Chemotherapy Resistance20.10.2026 13:02:00 CEST | Press release
Researchers from French National Centre for Scientific Research (CNRS), Institut Curie, Sorbonne Université and One Biosciences show ovarian cancer tumor cells may be epigenetically primed to resist chemotherapyClinical single-cell profiling at diagnosis may enable more personalized treatment strategies in difficult-to-treat cancer One Biosciences today announced data showing some ovarian cancer tumor cells are predisposed to resist chemotherapy and single-cell profiling at diagnosis can identify tumor profiles that indicate which patients are likely to experience treatment failure, ultimately enabling more personalized treatment strategies. Researchers from One Biosciences, French National Centre for Scientific Research (CNRS), Institut Curie, and Sorbonne Université found that the cellular changes linked to the development of resistance to cytotoxic chemotherapy cannot be explained by DNA mutations alone: the functional and epigenetic state of tumor cells play a key role and initial
IDWS 2026 Brings the World Together to Accelerate the Deployment of Water Solutions20.10.2026 12:38:00 CEST | Press release
Jeddah is preparing to host the fifth edition of the Innovation Driven Water Sustainability Conference (IDWS 2026) from 14 to 16 December 2026. The conference aims to accelerate the transition of water solutions from research and development to real-world deployment, while connecting innovators with investors and end users to strengthen water security, improve service efficiency, and enhance the sustainability of water resources worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261020192877/en/ Main session from IDWS 2025 (Photo: AETOSWire) The conference will bring together experts, researchers, innovators, investors, and representatives of water-sector organisations from more than 140 countries. It will feature over 250 speakers and is expected to attract more than 10,000 participants, alongside an international exhibition showcasing more than 150 global brands. Eng. Tariq Al-Ghafari, Deputy president for innovatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom